Skip to main content
logo
Viva Biotech Holdings (HKG:1873)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.910
-0.010 (-0.52%)
Apr 17, 2026, 3:45 PM HKT

Viva Biotech Holdings Revenue

In the year 2025, Viva Biotech Holdings had annual revenue of 1.73B CNY, down -12.95%. Viva Biotech Holdings had revenue of 897.57M in the half year ending December 31, 2025, a decrease of -11.43%.

Revenue
1.73B CNY
Revenue Growth
-12.95%
P/S Ratio
2.11
Revenue / Employee
797.35K CNY
Employees
2,169
Market Cap
4.05B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.73B-257.21M-12.95%
Dec 31, 20241.99B-168.93M-7.84%
Dec 31, 20232.16B-224.05M-9.42%
Dec 31, 20222.38B275.55M13.10%
Dec 31, 20212.10B1.41B201.90%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AIM Vaccine1.30B
Qyuns Therapeutics897.99M
Shandong Boan Biotechnology873.36M
BioDlink International Company831.99M
Medtide634.40M
Mirxes Holding Company166.32M
Antengene Corporation117.22M
Jiangsu Recbio Technology14.16M
Revenue Rankings

Viva Biotech Holdings News

More News